UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Recent progress in TGF-β inhibitors for cancer therapy

Biomedicine & pharmacotherapy, 2021-02, Vol.134, p.111046-111046, Article 111046

2021

Volltextzugriff (PDF)

Hepatitis B virus relapse rates in chronic hepatitis B patients who discontinue either entecavir or tenofovir

Alimentary pharmacology & therapeutics, 2019-01, Vol.49 (2), p.218-228

2019

Volltextzugriff (PDF)

Clinical Study of Single‐Stranded Oligonucleotide RO7062931 in Healthy Volunteers and Patients With Chronic Hepatitis B

Hepatology (Baltimore, Md.), 2021-10, Vol.74 (4), p.1795-1808

2021

Volltextzugriff (PDF)

Brivanib Versus Sorafenib As First-Line Therapy in Patients With Unresectable, Advanced Hepatocellular Carcinoma: Results From the Randomized Phase III BRISK-FL Study

Journal of clinical oncology, 2013-10, Vol.31 (28), p.3517-3524

2013

Volltextzugriff (PDF)

Higher rate of HBsAg loss after discontinuation of tenofovir than entecavir in patients with chronic hepatitis B

Alimentary pharmacology & therapeutics, 2023-08, Vol.58 (3), p.334-345

2023

Volltextzugriff (PDF)

The role of hepatitis B virus core‐related antigen in predicting hepatitis B virus relapse after cessation of entecavir in hepatitis B e antigen‐negative patients

Journal of viral hepatitis, 2021-08, Vol.28 (8), p.1141-1149

2021

Volltextzugriff (PDF)

Earlier and Higher Rate of Hepatitis B Virus Relapse After Discontinuing Tenofovir Versus Entecavir in Hepatitis B e Antigen-Positive Patients

The Journal of infectious diseases, 2022-06, Vol.225 (11), p.1974-1981

2022

Volltextzugriff (PDF)

Course and predictors of posttraumatic stress-related symptoms among family members of deceased ICU patients during the first year of bereavement

Critical care (London, England), 2021-08, Vol.25 (1), p.282-282, Article 282

2021

Volltextzugriff (PDF)

Incidence and predictors of retreatment in chronic hepatitis B patients after discontinuation of entecavir or tenofovir treatment

PloS one, 2019-10, Vol.14 (10), p.e0222221-e0222221

2019

Volltextzugriff (PDF)

HDGF stimulates liver tumorigenesis by enhancing reactive oxygen species generation in mitochondria

The Journal of biological chemistry, 2023-11, Vol.299 (11), p.105335, Article 105335

2023

Volltextzugriff (PDF)

Hepatitis B virus-related hepatocellular carcinoma has superior overall survival compared with other etiologies

PloS one, 2024, Vol.19 (3), p.e0290523-e0290523

2024

Volltextzugriff (PDF)

APRI and FIB-4 in the evaluation of liver fibrosis in chronic hepatitis C patients stratified by AST level

PloS one, 2018-06, Vol.13 (6), p.e0199760-e0199760

2018

Volltextzugriff (PDF)

Gut Microbiota Dysbiosis in Patients with Biopsy-Proven Nonalcoholic Fatty Liver Disease: A Cross-Sectional Study in Taiwan

Nutrients, 2020-03, Vol.12 (3), p.820

2020

Volltextzugriff (PDF)

How symptoms of prolonged grief disorder, posttraumatic stress disorder, and depression relate to each other for grieving ICU families during the first two years of bereavement

Critical care (London, England), 2022-11, Vol.26 (1), p.1-336, Article 336

2022

Volltextzugriff (PDF)

Morphomic Signatures Derived from Computed Tomography Predict Hepatocellular Carcinoma Occurrence in Cirrhotic Patients

Digestive diseases and sciences, 2020-07, Vol.65 (7), p.2130-2139

2020

Volltextzugriff (PDF)

ICU bereaved surrogates' comorbid psychological-distress states and their associations with prolonged grief disorder

Critical care (London, England), 2022-04, Vol.26 (1), p.102-102, Article 102

2022

Volltextzugriff (PDF)

The change in liver stiffness, controlled attenuation parameter and fibrosis-4 index for chronic hepatitis C patients with direct-acting antivirals

PloS one, 2019-04, Vol.14 (4), p.e0214323-e0214323

2019

Volltextzugriff (PDF)

Real‐world effectiveness of glecaprevir/pibrentasvir and ledipasvir/sofosbuvir for mixed genotype hepatitis C infection: A multicenter pooled analysis in Taiwan

Journal of viral hepatitis, 2020-09, Vol.27 (9), p.866-872

2020

Volltextzugriff (PDF)

2020 Taiwan consensus statement on the management of hepatitis C: Part (II) special populations

Journal of the Formosan Medical Association, 2020-07, Vol.119 (7), p.1135-1157

2020

Volltextzugriff (PDF)

Evolution of renal function under direct‐acting antivirals treatment for chronic hepatitis C: A real‐world experience

Journal of viral hepatitis, 2019-12, Vol.26 (12), p.1404-1412

2019

Volltextzugriff (PDF)

Evaluation of abdominal ultrasonography mass screening for hepatocellular carcinoma in Taiwan

Hepatology (Baltimore, Md.), 2014-05, Vol.59 (5), p.1840-1849

2014

Volltextzugriff (PDF)

Using the Diabetes Care System for a County-Wide Hepatitis C Elimination: An Integrated Community-Based Shared Care Model in Taiwan

The American journal of gastroenterology, 2024-05, Vol.119 (5), p.883-892

2024

Volltextzugriff (PDF)

Ledipasvir/Sofosbuvir for 8, 12, or 24 Weeks in Hepatitis C Patients Undergoing Dialysis for End-Stage Renal Disease

The American journal of gastroenterology, 2021-09, Vol.116 (9), p.1924-1928

2021

Volltextzugriff (PDF)

Incidence and predictors of HBV relapse after cessation of nucleoside analogues in HBeAg-negative patients with HBsAg ≤ 200 IU/mL

Scientific reports, 2017-05, Vol.7 (1), p.1839-9, Article 1839

2017

Volltextzugriff (PDF)

MicroRNAs in Hepatocellular Carcinoma : Carcinogenesis, Progression, and Therapeutic Target

BioMed research international, 2014-01, Vol.2014 (2014), p.1-11

2014

Volltextzugriff (PDF)

1 – 25 von 332

Suche als RSS-Feed

Aktive Filter

ThemaHepatocellular Carcinoma

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(298)
Mit Volltextzugriff
(294)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Recent progress in TGF-β inhibitors for cancer therapy

Hepatitis B virus relapse rates in chronic hepatitis B patients who discontinue either entecavir or tenofovir

Clinical Study of Single‐Stranded Oligonucleotide RO7062931 in Healthy Volunteers and Patients With Chronic Hepatitis B

Brivanib Versus Sorafenib As First-Line Therapy in Patients With Unresectable, Advanced Hepatocellular Carcinoma: Results From the Randomized Phase III BRISK-FL Study

Higher rate of HBsAg loss after discontinuation of tenofovir than entecavir in patients with chronic hepatitis B

The role of hepatitis B virus core‐related antigen in predicting hepatitis B virus relapse after cessation of entecavir in hepatitis B e antigen‐negative patients

Earlier and Higher Rate of Hepatitis B Virus Relapse After Discontinuing Tenofovir Versus Entecavir in Hepatitis B e Antigen-Positive Patients

Course and predictors of posttraumatic stress-related symptoms among family members of deceased ICU patients during the first year of bereavement

Incidence and predictors of retreatment in chronic hepatitis B patients after discontinuation of entecavir or tenofovir treatment

HDGF stimulates liver tumorigenesis by enhancing reactive oxygen species generation in mitochondria

Hepatitis B virus-related hepatocellular carcinoma has superior overall survival compared with other etiologies

APRI and FIB-4 in the evaluation of liver fibrosis in chronic hepatitis C patients stratified by AST level

Gut Microbiota Dysbiosis in Patients with Biopsy-Proven Nonalcoholic Fatty Liver Disease: A Cross-Sectional Study in Taiwan

How symptoms of prolonged grief disorder, posttraumatic stress disorder, and depression relate to each other for grieving ICU families during the first two years of bereavement

Morphomic Signatures Derived from Computed Tomography Predict Hepatocellular Carcinoma Occurrence in Cirrhotic Patients

ICU bereaved surrogates' comorbid psychological-distress states and their associations with prolonged grief disorder

The change in liver stiffness, controlled attenuation parameter and fibrosis-4 index for chronic hepatitis C patients with direct-acting antivirals

Real‐world effectiveness of glecaprevir/pibrentasvir and ledipasvir/sofosbuvir for mixed genotype hepatitis C infection: A multicenter pooled analysis in Taiwan

2020 Taiwan consensus statement on the management of hepatitis C: Part (II) special populations

Evolution of renal function under direct‐acting antivirals treatment for chronic hepatitis C: A real‐world experience

Evaluation of abdominal ultrasonography mass screening for hepatocellular carcinoma in Taiwan

Using the Diabetes Care System for a County-Wide Hepatitis C Elimination: An Integrated Community-Based Shared Care Model in Taiwan

Ledipasvir/Sofosbuvir for 8, 12, or 24 Weeks in Hepatitis C Patients Undergoing Dialysis for End-Stage Renal Disease

Incidence and predictors of HBV relapse after cessation of nucleoside analogues in HBeAg-negative patients with HBsAg ≤ 200 IU/mL

MicroRNAs in Hepatocellular Carcinoma : Carcinogenesis, Progression, and Therapeutic Target

Aktive Filter

Suchergebnisse filtern